CIS Pharma presenting ADC drug carrier technology at Swiss Biotech Day 2017

Basel, Switzerland, May 4th 2017 -- CIS Pharma presents its ADC drug carrier technology at Swiss Biotech Day 2017, scheduled for 14:10 during the Emerging Companies Streams. CIS Pharma ADC [...]

By | Mai 1st, 2017|ADC, Cellophil, Corporate|0 Comments

CIS Pharma appoints Dr. Christophe Thommen as new head of research and laboratory operations

Bubendorf, Switzerland, December 2016 -- CIS Pharma welcomes Dr. Christophe Thommen, who will lead the research team as the new head of research and laboratory operations. Christophe is an expert [...]

By | Dezember 1st, 2016|ADC, Cellophil, Corporate|0 Comments

CIS Pharma’s solubilization technology comprising cyclosporine A has entered proof of concept phase

Bubendorf, Switzerland October 2016 - CIS Pharma’s novel solubilization strategy for hydrophobic drugs has successfully reached the proof of concept phase. The Cellophil® Smart Polymer technology platform creates water-soluble formulations [...]

By | Oktober 1st, 2016|Cellophil, solubilization technology|0 Comments

CIS Pharma has successfully concluded the development of novel contact lens coating technology

Bubendorf, Switzerland, September 2016 -- CIS Pharma has concluded the development of a novel contact lens coating technology based on the Cellophil® Smart Polymer platform. The technology has been shown [...]

By | September 1st, 2016|Cellophil, ContactlensCoating|0 Comments

CIS Pharma announces the first milestones in its ADC research program are achieved

Bubendorf, Switzerland, January 2016 -- Proof of concept studies at NBE Therapeutics demonstrated conjugation of CIS Pharma’s Cellophil® Smart Polymer drug carrier to antibodies. Consequently, different linkers were evaluated for [...]

By | Januar 1st, 2016|ADC, Cellophil|0 Comments

CIS Pharma creates novel contact lens coating technology

Bubendorf, Switzerland, November 2015 -- CIS Pharma is expanding its Cellophil® Smart Polymer platform with new bio-inspired derivatives. The derivatives are used as building blocks for the development of a [...]

By | November 1st, 2015|Cellophil, ContactlensCoating|0 Comments

CIS Pharma develops solubilization technology for hydrophobic drugs

Bubendorf, Switzerland, September 2015 -- CIS Pharma has engaged in a research program to develop a new technology platform that creates water-soluble formulations of highly hydrophobic drugs. The approach comprises [...]

By | September 1st, 2015|Cellophil, solubilization technology|0 Comments

CIS Pharma appoints Davide Panighetti to its cancer research team

Bubendorf, Switzerland, April 2015 -- CIS Pharma welcomes Davide Panighetti, who reinforces the research team as the new synthesis chemist. Davide’s skills will boost the team working on proprietary drug [...]

By | April 1st, 2015|ADC, Cellophil, Corporate|0 Comments

CIS Pharma to develop drug carriers for ADCs

Bubendorf, Switzerland, January 2015 -- CIS Pharma has taken a strategic decision to extend its activity into the field of cancer treatments. The defined objective is to improve the potency [...]

By | Januar 1st, 2015|ADC, Cellophil|0 Comments